Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation.

MLA

Nelson, Beverly P., et al. “Early Posttransplant Lymphoproliferative Disease: Clinicopathologic Features and Correlation with MTOR Signaling Pathway Activation.” American Journal of Clinical Pathology, vol. 138, no. 4, Oct. 2012, pp. 568–78. EBSCOhost, https://doi.org/10.1309/AJCPQYYE04AVGVYI.

APA

Nelson, B. P., Wolniak, K. L., Evens, A., Chenn, A., Maddalozzo, J., & Proytcheva, M. (2012). Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation. American Journal of Clinical Pathology, 138(4), 568–578. https://doi.org/10.1309/AJCPQYYE04AVGVYI

Chicago

Nelson, Beverly P, Kristy L Wolniak, Andrew Evens, Anjen Chenn, John Maddalozzo, and Maria Proytcheva. 2012. “Early Posttransplant Lymphoproliferative Disease: Clinicopathologic Features and Correlation with MTOR Signaling Pathway Activation.” American Journal of Clinical Pathology 138 (4): 568–78. doi:10.1309/AJCPQYYE04AVGVYI.